.png){kind=logo}
National Health Authority (NHA) is the apex body responsible for implementing India's flagship public health insurance/assurance scheme called "Ayushman Bharat Pradhan Mantri Jan Arogya Yojana" & has been entrusted with the role of designing strategy, building technological infrastructure and implementation of "National Digital Health Mission" to create a National Digital Health Eco-system.
Displaying 12911 - 12920 of 26485
-
-
Ayushman Arogya Mandir is an attempt to move from a selective approach to health care to deliver comprehensive range of services spanning preventive, promotive, curative, rehabilitative and palliative care. It has two components which are complementary to each other. Under its first component, 1,50,000 Ayushman Arogya Mandir will be created to deliver Comprehensive Primary Health Care, that is universal and free to users, with a focus on wellness and the delivery of an expanded range of services closer to the community. The second component is the Pradhan Mantri Jan Arogya Yojana (PM-JAY)...
-
Reproductive and Child Health (RCH) Portal is designed for early identification and tracking of the individual beneficiary throughout the reproductive lifecycle of women and promote, monitor and support the reproductive, maternal, new-born and child health (RMNCH) schemes/programme delivery and reporting.
-
The e-Summons platform under Interoperable Criminal Justice System (ICJS) streamlines the process of Generation, Transmission, Execution and Reporting of Court Processes in Electronic form.
-
The Integrated Health Information Platform (IHIP) is a comprehensive digital initiative by the Ministry of Health and Family Welfare, Government of India, aimed at transforming India's public health surveillance system. The platform integrates and streamlines health information from various sources to provide real-time, actionable insights into public health data. It is designed to enhance the collection, management, and analysis of health data across the country, ultimately improving the quality and timeliness of health services and responses.
-
Materiovigilance Programme of India (MvPI) aims to collect data on medical device related adverse events systematically and scientifically analyze them to aid in regulatory decisions and recommendations on safe use of medical devices.
-
Pharmacovigilance Programme of India is Government of India's flagship drug safety monitoring programme, which collects, collates and analyses drug-related adverse events and send recommendations to CDSCO for taking appropriate regulatory actions.
-
IP Reference Substances, abbreviated to IPRS (and referred to as RS in the individual monographs) are issued by the Indian Pharmacopoeia Commission (IPC). They are the official standards to be used in cases of arbitration. Secondary Standards (Working Standards) may be used for routine analysis, provided they are standardized at regular intervals against the Reference Substances.
-
The National Formulary of India is essentially meant for the guidance of the members of the medical and pharmaceutical profession; medical students, nurses and pharmacists etc. working in hospitals, dispensaries and in sales establishments.
-
Indian Pharmacopoeia (IP) is published by the Indian Pharmacopoeia Commission (IPC) on behalf of the Ministry of Health & Family Welfare, Government of India in fulfillment of the requirements of the Drugs and Cosmetics Act, 1940 and Rules 1945 thereunder.